
Biotechnology Advances, Journal Year: 2025, Volume and Issue: unknown, P. 108568 - 108568
Published: March 1, 2025
Language: Английский
Biotechnology Advances, Journal Year: 2025, Volume and Issue: unknown, P. 108568 - 108568
Published: March 1, 2025
Language: Английский
Current Opinion in Biotechnology, Journal Year: 2024, Volume and Issue: 87, P. 103112 - 103112
Published: March 22, 2024
Curcumin, a potent plant polyketide in turmeric, has gained recognition for its outstanding health benefits, including anti-inflammatory, antioxidant, and anticancer effects. Classical turmeric farming, which is widely used to produce curcumin, linked deforestation, soil degradation, excessive water use, reduced biodiversity. In recent years, the microbial synthesis of curcumin been achieved optimized through novel strategies, offering increased safety, improved sustainability, potential revolutionize production. Here, we discuss breakthroughs engineering fermentation techniques, as well their capacity increase yield, purity, cost-effectiveness The utilization systems not only addresses supply chain limitations but also helps meet growing demand various industries, pharmaceuticals, foods, cosmetics.
Language: Английский
Citations
6Advanced Healthcare Materials, Journal Year: 2024, Volume and Issue: 13(22)
Published: May 7, 2024
Curcumin is a natural product found in the rhizome of Curcuma longa (L.) and other spp. As lipophilic molecule, it has greater affinity for polar, non-polar, alkaline, or extremely acidic organic solvents. Several studies indicate that curcumin several benefits human health, example, against degenerative diseases, cancer, infectious diseases. To obtain quality with nutraceutical properties, necessary to know its physicochemical characteristics preserve from cultivation until ingestion by human. However, low solubility leads absorption; this context, nanotechnological systems can contribute increase bioavailability. This review aims highlight important issues all stages goes through: aspects related extraction association nanotechnology. Although process already well established, possible observe more research focused on increasing yield being environmentally friendly. Further, curcumin's absorption notable due characteristics, mainly aqueous solubility. nanotechnology shows be promising an increasingly growing trend because use "Indian solid gold" hope many patients.
Language: Английский
Citations
6Molecules, Journal Year: 2022, Volume and Issue: 27(22), P. 7963 - 7963
Published: Nov. 17, 2022
Ischemic stroke (IS) is an acute cerebrovascular disease caused by sudden arterial occlusion, which characterized a high morbidity, mortality, and disability rate. It one of the most important causes nervous system morbidity mortality in world. In recent years, search for new medicine treatment IS has become attractive research focus. Due to extremely limited time window traditional treatment, some side effects may occur, accompanied occurrence adverse reactions, frequency exploration with natural significantly increased. Phosphatidylinositol-3-kinase/Protein kinase B (PI3K/Akt) signaling pathway classical cell metabolism, growth, apoptosis, other physiological activities. There considerable on that treats various diseases through this pathway. This review focuses how medicines (including herbs insects) regulate pathophysiological processes such as inflammation, oxidative stress, autophagy PI3K/Akt pathway, role it plays improving IS. We found many kinds herbal insect can alleviate damage Moreover, prescription after their combination also achieve certain results. Therefore, provides candidate category development
Language: Английский
Citations
27Frontiers in Pharmacology, Journal Year: 2022, Volume and Issue: 13
Published: Nov. 7, 2022
Central nervous system (CNS) disorders and diseases are expected to rise sharply in the coming years, partly because of world’s aging population. Medicines for treatment CNS have not been successfully made. Inadequate knowledge about brain, pharmacokinetic dynamic errors preclinical studies, challenges with clinical trial design, complexity variety human brain illnesses, variations species some potential scenarios. Neurodegenerative (NDDs) multifaceted lack identifiable etiological components, drugs developed treat them did meet requirements those who anticipated treatments. Therefore, there is a great demand safe effective natural therapeutic adjuvants. For NDDs other memory-related problems, many herbal items used Ayurvedic medical system. Anxiety, depression, Parkinson’s, Alzheimer’s (AD), as well plethora neuropsychiatric disorders, may benefit from use plant food-derived chemicals that antidepressant or antiepileptic properties. We summarized present level products based on topological evidence, bioinformatics analysis, translational research this review. also highlighted investigation will help us select neurological conditions. In review, we explored efficacy phytoconstituents against diseases. Various evidence-based studies extensive recent investigations included, which pharmacologists reduce progression neuronal disease.
Language: Английский
Citations
24AMB Express, Journal Year: 2023, Volume and Issue: 13(1)
Published: Nov. 28, 2023
Abstract Brain-Derived Neurotrophic Factor ( BDNF ) is a neurotrophin gene family that encodes proteins vital for the growth, maintenance, and survival of neurons in nervous system. The study aimed to screen natural compounds against variant (V66M), which affects memory, cognition, mood regulation. (V66M) as target structure was selected, Vitamin D, Curcumin, C, Quercetin ligands structures were taken from PubChem database. Multiple tools like AUTODOCK VINA, BIOVIA discovery studio, PyMOL, CB-dock, IMOD server, Swiss ADEMT, predict used analyze binding energy, interaction, stability, toxicity, visualize -ligand complexes. Compounds D3, with energies values − 5.5, 6.1, 4.5, 6.7 kj/mol, respectively, selected. bind active sites via hydrophobic bonds, hydrogen electrostatic interactions. Furthermore, ADMET analysis revealed they exhibited sound pharmacokinetic toxicity profiles. In addition, an MD simulation showed most ligand bound favorably dynamically protein, protein–ligand complex stability determined. finding this research could provide excellent platform discovering rationalizing novel drugs stress related (V66M). Docking, preclinical drug testing results suggest more potent inhibitor forming structurally stable complex.
Language: Английский
Citations
15Neural Regeneration Research, Journal Year: 2023, Volume and Issue: 19(3), P. 512 - 518
Published: July 20, 2023
Abstract CD36 is a highly glycosylated integral membrane protein that belongs to the scavenger receptor class B family and regulates pathological progress of metabolic diseases. was recently found be widely expressed in various cell types nervous system, including endothelial cells, pericytes, astrocytes, microglia. mediates number regulatory processes, such as dysfunction, oxidative stress, mitochondrial inflammatory responses, which are involved many central system diseases, stroke, Alzheimer’s disease, Parkinson’s spinal cord injury. antagonists can suppress expression or prevent binding its ligand, thereby achieving inhibition CD36-mediated pathways functions. Here, we reviewed mechanisms action antagonists, Salvianolic acid B, tanshinone IIA, curcumin, sulfosuccinimidyl oleate, antioxidants, small-molecule compounds. Moreover, predicted structures sites between antagonists. These provide targets for more efficient safer treatment
Language: Английский
Citations
14Drug Design Development and Therapy, Journal Year: 2024, Volume and Issue: Volume 18, P. 2869 - 2881
Published: July 1, 2024
Parkinson's disease (PD) is the most prevalent movement disorder. Curcumin, a polyphenol with hydrophobic properties, has been proved against Parkinson. Our previous study suggested that curcumin's effectiveness in treating may be linked to gut-brain axis, although specific mechanism by which curcumin exerts neuroprotective effects brain remains unknown.
Language: Английский
Citations
4Life Sciences, Journal Year: 2025, Volume and Issue: unknown, P. 123402 - 123402
Published: Jan. 1, 2025
Language: Английский
Citations
0Molecular Biology Reports, Journal Year: 2025, Volume and Issue: 52(1)
Published: Feb. 13, 2025
Language: Английский
Citations
0Inflammopharmacology, Journal Year: 2025, Volume and Issue: unknown
Published: Feb. 16, 2025
Language: Английский
Citations
0